Aberrant microRNA expression in human cervical carcinomas.
Because altered microRNAs (miRNAs) expression patterns have been observed in a variety of diseased tissues, miRNA expression was compared in human cervical cancer tissues relative to adjacent normal cervical tissues in the present study. Microarray chips with 924 probes were used to detect the expression of miRNAs in cervical cancer tissue and adjacent normal cervical tissue of 13 patients with cervical cancer (11 squamous cervical cancers, one cervical adenocarcinoma, and one cervical sarcoma), all of whom were infected with human papilloma virus (HPV) 16 and/or HPV18. Compared to the expression levels in normal cervical tissues, 18 miRNAs (1.9%) were significantly upregulated (increase of ≥2×), and 19 miRNAs (2.1%) were significantly downregulated (decrease of ≤0.5×) in cervical cancer tissues. miRNA expression was independent of lymph node involvement, vascular invasion, and pathological differentiation. Taken together, cervical cancer tissues have altered expression of miRNAs relative to adjacent normal tissues. Further studies are necessary to determine whether aberrant miRNA expression is related to the pathogenesis of cervical cancer.
Department of Gynecologic Oncology, The Second Affiliated Hospital of SunYat-sen University, 510120 Guangzhou, People's Republic of China.
Qunxian
Q
Rao
Qingli
Q
Shen
Hui
H
Zhou
Yongpai
Y
Peng
Jing
J
Li
Zhongqiu
Z
Lin
D000230:Adenocarcinoma / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D002584:Cervix Uteri / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008207:Lymphatic Metastasis; D035683:MicroRNAs / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D012509:Sarcoma / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics*
D014408:Biomarkers, Tumor; D035683:MicroRNAs
J Virol. 2006 Sep;80(17):8778-86
16912324
Cancer Res. 2010 Nov 1;70(21):8822-31
20978205
Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60
19640172
Gynecol Oncol. 2010 May;117(2):287-90
20163849
Biochem Biophys Res Commun. 2010 Apr 16;394(4):921-7
20230785
Cancer Res. 2010 Feb 15;70(4):1441-8
20124485
Cancer Res. 2009 Jul 15;69(14):5776-83
19584273
Nature. 2005 Jun 2;435(7042):682-6
15931223
Head Neck. 2011 Apr;33(4):504-12
20652977
Mol Cells. 2005 Feb 28;19(1):1-15
15750334
Eur J Cancer Prev. 2009 Feb;18(1):50-5
19077565
Cancer. 2010 Jan 1;116(1):41-9
19890957
J Clin Pathol. 2002 Apr;55(4):244-65
11919208
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
14973191
J Obstet Gynaecol Res. 2009 Oct;35(5):842-9
20149030
PLoS One. 2008 Jul 02;3(7):e2557
18596939
Carcinogenesis. 2010 Jun;31(6):1037-44
20351093
Nature. 2005 Jun 9;435(7043):839-43
15944709
PLoS One. 2010 Jul 26;5(7):e11780
20668671
Oncogene. 2008 Apr 17;27(18):2575-82
17998940
Drug Resist Updat. 2010 Jun;13(3):57-66
20236855
Nat Methods. 2004 Oct;1(1):47-53
15782152
Science. 2005 Apr 22;308(5721):557-60
15845854
Genome Biol. 2007;8(10):R214
17922911
Nature. 2006 Jul 6;442(7098):82-5
16738545
J Pathol. 1999 Sep;189(1):12-9
10451482
Genome Res. 2004 Dec;14(12):2486-94
15574827